GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tlx2 | mm10_v2_chr6_-_83070225_83070377 | -0.20 | 2.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_105933832 Show fit | 2.41 |
ENSMUST00000034368.6
|
chymotrypsin-like |
|
chr7_-_30924169 Show fit | 2.18 |
ENSMUST00000074671.6
|
hepcidin antimicrobial peptide 2 |
|
chr1_-_150466165 Show fit | 1.98 |
ENSMUST00000162367.1
ENSMUST00000161611.1 ENSMUST00000161320.1 ENSMUST00000159035.1 |
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
|
chr8_-_111691002 Show fit | 1.94 |
ENSMUST00000034435.5
|
chymotrypsinogen B1 |
|
chr3_-_98630309 Show fit | 1.89 |
ENSMUST00000044094.4
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 |
|
chr17_-_31144271 Show fit | 1.88 |
ENSMUST00000024826.7
|
trefoil factor 2 (spasmolytic protein 1) |
|
chr8_+_105048592 Show fit | 1.74 |
ENSMUST00000093222.5
ENSMUST00000093223.3 |
carboxylesterase 3A |
|
chr17_-_84682932 Show fit | 1.63 |
ENSMUST00000066175.3
|
ATP-binding cassette, sub-family G (WHITE), member 5 |
|
chr15_+_77729091 Show fit | 1.58 |
ENSMUST00000109775.2
|
apolipoprotein L 9b |
|
chr5_+_137981512 Show fit | 1.48 |
ENSMUST00000035390.5
|
alpha-2-glycoprotein 1, zinc |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.0 | 2.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.9 | 2.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 2.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.5 | 2.2 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.1 | 2.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 2.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 1.8 | GO:0007586 | digestion(GO:0007586) |
0.4 | 1.7 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.2 | 1.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 1.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 1.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 11.4 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.2 | 4.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 3.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 2.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 2.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 2.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 2.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 1.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |